arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

PAVmed Inc.

PAVM
$4.05 ▲ +0.02 (+0.62%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
46 Visible periods
25 Metrics
Peer-ranked Benchmarks
Price Chart
33
Health
Poor
Neutral
auto_awesome

Analytical Summary

PAVmed Inc. shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $25.4M
Dividend Yield
Revenue Growth 450.0%
Op. Margin
ROIC -20.0%
FCF / Share $-0.43
Trailing P/E
Price / Book 0.7x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Sep 23, 2026.

46-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$33.00K
↑ +450.0%
Net Income Profit after all expenses
$-5.38M
↑ +54.8%
FCF / Share Free cash flow per share
$-0.43
↑ +74.5%

Health Breakdown

Returns
46
Cash Quality
1

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 12 years · 46 quarters